Informations:
Erreur:
ID
26594
Description
Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00820690
Lien
https://clinicaltrials.gov/show/NCT00820690
Mots-clés
Versions (1)
- 20/10/2017 20/10/2017 -
Détendeur de droits
See clinicaltrials.gov
Téléchargé le
20 octobre 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Breast Cancer NCT00820690
Eligibility Breast Cancer NCT00820690
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00820690
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Gender | Locally advanced breast cancer
Item
women with locally advanced women breast cancer
boolean
C0079399 (UMLS CUI [1])
C3495949 (UMLS CUI [2])
C3495949 (UMLS CUI [2])
Histology Ductal | Histology Invasive Lobular
Item
histology: ductal ou lobular invasive histology
boolean
C0344441 (UMLS CUI [1,1])
C1512083 (UMLS CUI [1,2])
C0344441 (UMLS CUI [2,1])
C0205281 (UMLS CUI [2,2])
C0205417 (UMLS CUI [2,3])
C1512083 (UMLS CUI [1,2])
C0344441 (UMLS CUI [2,1])
C0205281 (UMLS CUI [2,2])
C0205417 (UMLS CUI [2,3])
Informed Consent
Item
agreement to take part in the study and signature of the informed consent
boolean
C0021430 (UMLS CUI [1])
Condition Clinical Receive Doxorubicin | Condition Clinical Receive Cyclophosphamide | Condition Clinical Receive Paclitaxel
Item
clinical condition to receive doxorubicin/cyclophosphamide and paclitaxel
boolean
C0348080 (UMLS CUI [1,1])
C0205210 (UMLS CUI [1,2])
C1514756 (UMLS CUI [1,3])
C0013089 (UMLS CUI [1,4])
C0348080 (UMLS CUI [2,1])
C0205210 (UMLS CUI [2,2])
C1514756 (UMLS CUI [2,3])
C0010583 (UMLS CUI [2,4])
C0348080 (UMLS CUI [3,1])
C0205210 (UMLS CUI [3,2])
C1514756 (UMLS CUI [3,3])
C0144576 (UMLS CUI [3,4])
C0205210 (UMLS CUI [1,2])
C1514756 (UMLS CUI [1,3])
C0013089 (UMLS CUI [1,4])
C0348080 (UMLS CUI [2,1])
C0205210 (UMLS CUI [2,2])
C1514756 (UMLS CUI [2,3])
C0010583 (UMLS CUI [2,4])
C0348080 (UMLS CUI [3,1])
C0205210 (UMLS CUI [3,2])
C1514756 (UMLS CUI [3,3])
C0144576 (UMLS CUI [3,4])
ECOG performance status
Item
ecog 0 or i
boolean
C1520224 (UMLS CUI [1])
TNM clinical staging
Item
not clinical stage iii
boolean
C3258246 (UMLS CUI [1])
Inflammatory Breast Carcinoma
Item
inflammatory breast cancer
boolean
C0278601 (UMLS CUI [1])
Prior Therapy
Item
previous treatment
boolean
C1514463 (UMLS CUI [1])
Malignant Neoplasms | Exception Basal cell carcinoma | Exception Squamous cell carcinoma of skin | Exception Cervix carcinoma
Item
previous diagnosis of cancer (except basal cell or squamous cell skin carcinoma and non-invasive cervical carcinoma)
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0553723 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0302592 (UMLS CUI [4,2])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0553723 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0302592 (UMLS CUI [4,2])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Absence Condition Receive Chemotherapy
Item
absence of clinical condition to receive chemotherapy
boolean
C0332197 (UMLS CUI [1,1])
C0348080 (UMLS CUI [1,2])
C1514756 (UMLS CUI [1,3])
C0392920 (UMLS CUI [1,4])
C0348080 (UMLS CUI [1,2])
C1514756 (UMLS CUI [1,3])
C0392920 (UMLS CUI [1,4])